The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Daniel J. Blackman

Showing 1-7 of 7 articles
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Coronary interventions
Post-procedural myocardial infarction following surgical aortic valve replacement and transcatheter aortic valve implantation
Dobson L, Musa T, Uddin A, Fairbairn T, Swoboda P, Ripley D, Garg P, Evans B, Malkin C, Blackman D, Plein S, Greenwood J
June 2, 2017 | 10.4244/EIJ-D-16-00558
Interventions for valvular disease
Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry
Malkin C, Long W, Baxter P, Gale C, Wendler O, Monaghan M, Thomas M, Ludman P, De Belder M, Cunningham A, Moat N, Blackman D
February 19, 2016 | 10.4244/EIJY14M12_12
Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population
Shelton R, Eftychiou C, Somers K, Liu A, Burton-Wood N, Anderson M, Makri L, Blaxill J, McLenachan J, Wheatcroft S, Greenwood J, Blackman D
May 21, 2013 | 10.4244/EIJV9I1A17
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design
Kelly D, McCann G, Blackman D, Curzen N, Dalby M, Greenwood J, Fairbrother K, Shipley L, Kelion A, Heatherington S, Khan J, Nazir S, Alahmar A, Flather M, Swanton H, Schofield P, Gunning M, Hall R, Gershlick A
February 22, 2013 | 10.4244/EIJV8I10A183
Complications of transcatheter aortic valve implantation: avoidance and management
Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, MacCarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N
September 30, 2011 | 10.4244/EIJV7I5A99

Latest news

NEW ISSUE
Radiation protection, ticagrelor monotherapy, the COMPARE-ABSORB trial, the BASILICA technique...
BASILICA technique procedure recorded from aortic and left ventricular
October 23, 2020
NEW
READ NOW: 15th EBC consensus on bifurcation
Just Accepted Article
October 21, 2020
EDitorial
Occupational radiation exposure in interventional cardiology – time for further action
Robert A. Byrne
October 23, 2020
JAA
This Week's JAA's: Impact of intervention strategies after failed TMVR, Invasive assessment of a myocardial bridge...
October 20, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction
Josep Rodés-Cabau
October 23, 2020
Spyral, Popular-Tavi, Sort out IX, Solve TAVI, and more
(Released thanks to the support of Biotronik)
September 30, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke